The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial

Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week...

Full description

Saved in:
Bibliographic Details
Published inGut microbes Vol. 13; no. 1; pp. 1 - 11
Main Authors Vijay, Amrita, Astbury, Stuart, Le Roy, Caroline, Spector, Tim D, Valdes, Ana M
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.01.2021
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10 −3 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
AbstractList Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10-3) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = -0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = -0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp . and Bacteroides spp , and significant decreases in the fatty-liver associated Collinsella spp . On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate ( p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate ( p < .002) and nearly significant increases in butyrate ( p < .053). Coprococcus , which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10 −3 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
Prebiotics are compounds in food that benefit health affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in . and , and significant decreases in the fatty-liver associated . On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate ( < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate ( < .002) and nearly significant increases in butyrate ( < .053). , which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), = 1.4 x 10 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = -0.381 (0.01), = .001) and VLDL-TG (Beta (SE) = -0.372 (0.04), = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10−3) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome composition and are widely accepted to have health benefits, although recent large trials have been inconclusive. We carried out a 6-week dietary intervention comparing the effects of daily supplementation with 500 mg of omega-3 versus 20 g of a well-characterized prebiotic, inulin. Inulin supplementation resulted in large increases in Bifidobacterium and Lachnospiraceae. In contrast, omega-3 supplementation resulted in significant increases in Coprococcus spp. and Bacteroides spp, and significant decreases in the fatty-liver associated Collinsella spp. On the other hand, similar to the results with inulin supplementation which resulted in significant increases in butyrate, iso-valerate, and iso-butyrate (p < .004), omega-3 supplementation resulted in significant increases in iso-butyrate and isovalerate (p < .002) and nearly significant increases in butyrate (p < .053). Coprococcus, which was significantly increased post-supplementation with omega-3, was found to be positively associated with iso-butyric acid (Beta (SE) = 0.69 (0.02), P = 1.4 x 10 −3 ) and negatively associated with triglyceride-rich lipoproteins such as VLDL (Beta (SE) = −0.381 (0.01), P = .001) and VLDL-TG (Beta (SE) = −0.372 (0.04), P = .001) after adjusting for confounders. Dietary omega-3 alters gut microbiome composition and some of its cardiovascular effects appear to be potentially mediated by its effect on gut microbial fermentation products indicating that it may be a prebiotic nutrient.
Author Vijay, Amrita
Spector, Tim D
Astbury, Stuart
Le Roy, Caroline
Valdes, Ana M
Author_xml – sequence: 1
  givenname: Amrita
  orcidid: 0000-0002-9595-5680
  surname: Vijay
  fullname: Vijay, Amrita
  email: amrita.vijay@nottingham.ac.uk
  organization: School of Medicine, University of Nottingham
– sequence: 2
  givenname: Stuart
  orcidid: 0000-0002-1919-3952
  surname: Astbury
  fullname: Astbury, Stuart
  organization: Nottingham University Hospitals NHS Trust and the University of Nottingham
– sequence: 3
  givenname: Caroline
  surname: Le Roy
  fullname: Le Roy, Caroline
  organization: King's College London
– sequence: 4
  givenname: Tim D
  surname: Spector
  fullname: Spector, Tim D
  organization: King's College London
– sequence: 5
  givenname: Ana M
  orcidid: 0000-0003-1141-4471
  surname: Valdes
  fullname: Valdes, Ana M
  organization: Nottingham University Hospitals NHS Trust and the University of Nottingham
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33382352$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv1DAUhSNUREvpTwB5ySbFb8csEFXFo1IlNmVtOc711CWJB9vTdv49DjMd0Q3e2Do-97u-Pq-boznO0DRvCT4nuMMfiOYaayXPKaZV6iQjjL1oTha9xbrjR4ezksfNWc53uC7OFZbsVXPMGOsoE_SkgZtbQOsEfYglOATegysZRY_iBCvbMuRtKVtkXRhQ3qzXI0wwF1tCnD-iC5TDY_sA8AslOw9xChkGFOYC6b66qgeVFOz4pnnp7ZjhbL-fNj-_frm5_N5e__h2dXlx3TrBeGlZp2mPpaaaik7YHhOh_SA55YoLqQU46oQblFJeKE6s7J1noMBbpYWgjJ02VzvuEO2dWacw2bQ10QbzV4hpZWyqc45gPJGc2x64rXBMnfYcNBDKe1Lb9LyyPu1Y600_weDqPMmOz6DPb-Zwa1bx3ijVEUkXwPs9IMXfG8jF1O9xMI52hrjJZpmKS9FJXK1iZ3Up5pzAH9oQbJbEzVPiZknc7BOvde_-feOh6infavi8M4TZxzTZh5jGwRS7HWPyNTIXsmH_7_EHQTS9AQ
CitedBy_id crossref_primary_10_1016_j_redox_2023_102730
crossref_primary_10_1097_ICL_0000000000000905
crossref_primary_10_3390_nu15122675
crossref_primary_10_3390_metabo14060311
crossref_primary_10_1080_19490976_2021_1897212
crossref_primary_10_1016_j_ncl_2023_07_005
crossref_primary_10_1038_s41467_024_45332_w
crossref_primary_10_3389_fpsyt_2023_1193490
crossref_primary_10_1007_s00394_021_02785_9
crossref_primary_10_3390_jcm10132903
crossref_primary_10_3389_fnut_2023_1205377
crossref_primary_10_1097_MCO_0000000000000865
crossref_primary_10_1080_10408398_2022_2142194
crossref_primary_10_1093_jn_nxab113
crossref_primary_10_1128_spectrum_02416_22
crossref_primary_10_3390_nu14224776
crossref_primary_10_1080_19490976_2022_2126274
crossref_primary_10_3390_nu14153099
crossref_primary_10_3389_fnut_2022_847114
crossref_primary_10_1155_2024_8925691
crossref_primary_10_1016_j_jconrel_2024_03_039
crossref_primary_10_3389_fnut_2022_854725
crossref_primary_10_1016_j_csbj_2023_10_035
crossref_primary_10_1016_j_tips_2022_02_001
crossref_primary_10_3390_nu16071054
crossref_primary_10_1016_j_phymed_2023_155068
crossref_primary_10_1038_s41522_022_00287_y
crossref_primary_10_59118_HUGX5553
crossref_primary_10_3390_nu16050694
crossref_primary_10_1016_j_ijsu_2022_106751
crossref_primary_10_3390_nu14010145
crossref_primary_10_1016_j_chom_2022_04_016
crossref_primary_10_3390_microorganisms10091727
crossref_primary_10_2147_DDDT_S404479
crossref_primary_10_3389_fnut_2024_1327863
crossref_primary_10_3390_nu14030614
crossref_primary_10_1080_19390211_2023_2198007
crossref_primary_10_3389_fmolb_2023_1182643
crossref_primary_10_1093_ajcn_nqac151
crossref_primary_10_3390_nu14142970
crossref_primary_10_1017_gmb_2023_14
crossref_primary_10_1080_19490976_2021_1997559
crossref_primary_10_1007_s00284_023_03223_1
crossref_primary_10_3390_nu14173545
crossref_primary_10_3389_fcvm_2021_691564
crossref_primary_10_3390_foods11020146
crossref_primary_10_3390_metabo11080531
crossref_primary_10_3389_fpsyt_2022_904426
crossref_primary_10_1080_09546634_2023_2299107
crossref_primary_10_2147_IDR_S390582
crossref_primary_10_3390_nu15224802
crossref_primary_10_1038_s41598_024_57627_5
crossref_primary_10_1080_19490976_2022_2120344
crossref_primary_10_3390_nu14122504
crossref_primary_10_3390_ijms25010438
crossref_primary_10_1016_j_jnutbio_2023_109326
crossref_primary_10_3390_fermentation9020126
crossref_primary_10_1017_S0007114521003251
crossref_primary_10_1097_YCO_0000000000000758
crossref_primary_10_1097_TP_0000000000004629
crossref_primary_10_1016_j_tifs_2023_104141
crossref_primary_10_1016_j_xcrm_2023_100993
crossref_primary_10_1016_j_ijbiomac_2022_03_063
Cites_doi 10.1136/gutjnl-2017-314968
10.1128/AEM.68.10.5186-5190.2002
10.1186/s12944-019-1167-4
10.3390/biom9040121
10.1038/s41598-019-48775-0
10.1016/S0140-6736(18)31809-9
10.1186/s40168-020-00887-w
10.1038/nrgastro.2017.75
10.1155/2014/348959
10.1186/1476-511X-13-140
10.1038/nature12820
10.1080/07315724.2002.10719248
10.3109/08830180903197480
10.1161/CIRCGENETICS.114.000216
10.1038/nature11319
10.1161/HYPERTENSIONAHA.107.090720
10.1038/nrmicro3344
10.1126/scitranslmed.3004244
10.1056/NEJMoa1804989
10.1093/advances/nmz074
10.1007/s11883-004-0087-5
10.3390/nu11061381
10.1111/apt.13746
10.3390/ijms21041249
10.1038/ismej.2017.196
10.1079/PNS2002207
10.1017/S0007114512001560
10.1016/j.chom.2018.05.012
10.1038/s41598-017-10382-2
10.1161/CIRCRESAHA.118.314642
10.1007/s10096-018-3220-z
10.1186/s12944-016-0245-0
10.1126/science.1223813
10.1136/heart.89.12.1445
10.1136/gutjnl-2015-310861
10.1096/fj.201802445R
10.1080/19490976.2017.1299309
10.1111/j.1365-277X.2005.00593.x
10.1001/2012.jama.11374
10.1038/s41598-017-16189-5
10.1371/journal.pone.0238006
10.1016/j.cell.2016.05.041
10.1038/s41598-019-52678-5
10.1016/j.chom.2016.04.017
10.1038/s41467-019-12476-z
10.1056/NEJMoa1811403
10.1128/microbiolspec.BAD-0019-2017
10.1080/17512433.2017.1333902
10.1016/j.cell.2014.09.053
10.1056/NEJMoa1812792
ContentType Journal Article
Copyright 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020
2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 The Author(s)
Copyright_xml – notice: 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020
– notice: 2020 The Author(s). Published with license by Taylor & Francis Group, LLC. 2020 The Author(s)
DBID 0YH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1080/19490976.2020.1863133
DatabaseName Taylor & Francis Open Access Journals
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access Journals
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate A. VIJAY ET AL
EISSN 1949-0984
EndPage 11
ExternalDocumentID oai_doaj_org_article_f1644abe4a47402c9f4e9e124b1ec2b4
10_1080_19490976_2020_1863133
33382352
1863133
Genre Research Paper
Randomized Controlled Trial
Journal Article
GrantInformation_xml – fundername: Medical Research Council
  grantid: MR/N01183X/1
GroupedDBID ---
00X
0R~
0YH
30N
4.4
53G
AAAVI
AAJNR
ABBKH
ABJVF
ABPEM
ABQHQ
ACGFS
ACTIO
ADBBV
ADCVX
AEGYZ
AEISY
AFOLD
AHDLD
AIJEM
AIRXU
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AQRUH
BABNJ
BAWUL
BLEHA
CCCUG
DGEBU
DIK
DKSSO
EBS
EMOBN
F5P
FUNRP
FVPDL
GROUPED_DOAJ
HYE
KYCEM
LJTGL
M4Z
MM.
O9-
OK1
RPM
SNACF
SV3
TFL
TFT
TFW
TR2
TTHFI
V1K
ZGOLN
ABCCY
AGYJP
C1A
CGR
CUY
CVF
ECM
EIF
EJD
H13
IPNFZ
NPM
OVD
RIG
TDBHL
TEORI
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c534t-3892b069292585ab0159fd6424745695ec2c5cd777f5741a6bcf3e7efa7955233
IEDL.DBID RPM
ISSN 1949-0976
IngestDate Tue Oct 22 15:02:07 EDT 2024
Tue Sep 17 21:26:17 EDT 2024
Fri Aug 16 22:34:05 EDT 2024
Fri Aug 23 00:42:24 EDT 2024
Sat Sep 28 08:34:02 EDT 2024
Fri Jun 09 04:11:43 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Gut microbiota
Omega 3
Fibre
Dietary intervention
Prebiotic
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-3892b069292585ab0159fd6424745695ec2c5cd777f5741a6bcf3e7efa7955233
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-1919-3952
0000-0002-9595-5680
0000-0003-1141-4471
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781624/
PMID 33382352
PQID 2474465860
PQPubID 23479
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_f1644abe4a47402c9f4e9e124b1ec2b4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7781624
crossref_primary_10_1080_19490976_2020_1863133
informaworld_taylorfrancis_310_1080_19490976_2020_1863133
proquest_miscellaneous_2474465860
pubmed_primary_33382352
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Gut microbes
PublicationTitleAlternate Gut Microbes
PublicationYear 2021
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References cit0033
cit0034
cit0031
cit0032
cit0030
Astbury S (cit0044) 2019; 07
cit0039
cit0037
cit0038
cit0035
cit0036
cit0022
cit0023
cit0020
cit0021
cit0028
cit0029
cit0026
cit0027
cit0024
cit0025
cit0011
cit0012
cit0010
Mori TA (cit0050) 2010; 56
cit0051
cit0052
cit0019
cit0017
cit0018
cit0015
cit0016
cit0013
cit0014
cit0001
cit0045
cit0042
cit0043
cit0040
cit0041
cit0008
cit0009
cit0006
cit0007
cit0004
cit0048
cit0005
cit0049
cit0002
cit0046
cit0003
cit0047
References_xml – ident: cit0021
  doi: 10.1136/gutjnl-2017-314968
– ident: cit0037
  doi: 10.1128/AEM.68.10.5186-5190.2002
– ident: cit0022
  doi: 10.1186/s12944-019-1167-4
– ident: cit0047
  doi: 10.3390/biom9040121
– ident: cit0048
  doi: 10.1038/s41598-019-48775-0
– ident: cit0052
  doi: 10.1016/S0140-6736(18)31809-9
– ident: cit0009
  doi: 10.1186/s40168-020-00887-w
– ident: cit0011
  doi: 10.1038/nrgastro.2017.75
– ident: cit0020
  doi: 10.1155/2014/348959
– ident: cit0024
  doi: 10.1186/1476-511X-13-140
– ident: cit0004
  doi: 10.1038/nature12820
– ident: cit0040
  doi: 10.1080/07315724.2002.10719248
– ident: cit0015
  doi: 10.3109/08830180903197480
– volume: 07
  start-page: 1
  year: 2019
  ident: cit0044
  publication-title: Gut Microbes
  contributor:
    fullname: Astbury S
– ident: cit0033
  doi: 10.1161/CIRCGENETICS.114.000216
– ident: cit0005
  doi: 10.1038/nature11319
– ident: cit0049
  doi: 10.1161/HYPERTENSIONAHA.107.090720
– ident: cit0038
  doi: 10.1038/nrmicro3344
– ident: cit0002
  doi: 10.1126/scitranslmed.3004244
– ident: cit0041
  doi: 10.1056/NEJMoa1804989
– ident: cit0012
  doi: 10.1093/advances/nmz074
– ident: cit0016
  doi: 10.1007/s11883-004-0087-5
– ident: cit0051
  doi: 10.3390/nu11061381
– ident: cit0026
  doi: 10.1111/apt.13746
– ident: cit0034
  doi: 10.3390/ijms21041249
– ident: cit0035
  doi: 10.1038/ismej.2017.196
– ident: cit0036
  doi: 10.1079/PNS2002207
– ident: cit0014
  doi: 10.1017/S0007114512001560
– ident: cit0007
  doi: 10.1016/j.chom.2018.05.012
– ident: cit0018
  doi: 10.1038/s41598-017-10382-2
– ident: cit0032
  doi: 10.1161/CIRCRESAHA.118.314642
– ident: cit0031
  doi: 10.1007/s10096-018-3220-z
– ident: cit0019
  doi: 10.1186/s12944-016-0245-0
– ident: cit0001
  doi: 10.1126/science.1223813
– ident: cit0027
  doi: 10.1136/heart.89.12.1445
– ident: cit0030
  doi: 10.1136/gutjnl-2015-310861
– ident: cit0043
  doi: 10.1096/fj.201802445R
– ident: cit0003
  doi: 10.1080/19490976.2017.1299309
– ident: cit0025
  doi: 10.1111/j.1365-277X.2005.00593.x
– ident: cit0039
  doi: 10.1001/2012.jama.11374
– ident: cit0046
  doi: 10.1038/s41598-017-16189-5
– ident: cit0006
  doi: 10.1371/journal.pone.0238006
– ident: cit0008
  doi: 10.1016/j.cell.2016.05.041
– ident: cit0023
  doi: 10.1038/s41598-019-52678-5
– ident: cit0029
  doi: 10.1016/j.chom.2016.04.017
– ident: cit0045
  doi: 10.1038/s41467-019-12476-z
– ident: cit0017
  doi: 10.1056/NEJMoa1811403
– ident: cit0010
  doi: 10.1128/microbiolspec.BAD-0019-2017
– ident: cit0013
  doi: 10.1080/17512433.2017.1333902
– ident: cit0028
  doi: 10.1016/j.cell.2014.09.053
– ident: cit0042
  doi: 10.1056/NEJMoa1812792
– volume: 56
  start-page: 83
  year: 2010
  ident: cit0050
  publication-title: Cell Mol Biol
  contributor:
    fullname: Mori TA
SSID ssj0000447063
Score 2.5258162
Snippet Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut...
Prebiotics are compounds in food that benefit health affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut microbiome...
Prebiotics are compounds in food that benefit health via affecting the gut microbiome. Omega-3 fatty acids have been associated with differences in gut...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1
SubjectTerms Aged
Bacteria - classification
Bacteria - genetics
Bacteria - isolation & purification
Bacteria - metabolism
Body Mass Index
Dietary intervention
Dietary Supplements
Fatty Acids - blood
Fatty Acids, Omega-3 - administration & dosage
Fatty Acids, Omega-3 - pharmacology
Female
Fibre
Gastrointestinal Microbiome - drug effects
Gut microbiota
Humans
Inulin - administration & dosage
Inulin - pharmacology
Lipids - blood
Male
Middle Aged
Omega 3
Prebiotic
Prebiotics - administration & dosage
Research Paper
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na94wDDalMOhl7KPb0n3gQa9pE9ux4966sVIG26mF3oztyFsYS0rflLb_vrKdt-Qtg152VRKwJTl6HluWCNlX3Fnd1qLsRCVKAZ0oW0CyojuQTFiEAOmW64-f8vRcfL9oLhatvmJOWC4PnBV3GBDPC-sAv1PIdbwOAjRgVHI1eOZyJdBKL8hU-gcLoXIbNSTpMSdIyfX1nbY6jLIoQnrIUNRKXnO-EZhS_f5H1Uv_hUEfp1IuYtPJC_J8BpX0OE_mJdmC4RV5lttM3r0mgL5AL6_A9SO-QOcUDjoGOv6FX7bkNNhpuqPW9x1dxTafOaU82uyIHtNVf1veAPyhGNe6ER0DOtovciVpav2xS85Pvp19PS3n9gqlb7iYSoQqzFUS8RFDzmAdAgMdOuQjqOhG6gbV6xvfKaVCg7jDSucDBwXBKt0gf-VvyPYwDvCOUBGCCI77wKwXtai1Q9xppeU184CUpCAHa92ay1xFw9RzcdK1MUw0hpmNUZAv0QIPL8ci2EmArmFm1zBPuUZB9NJ-Zkp7ICE3LDH8iQF8XhvboF7jKYodYLxemagegbhNVgV5m43_MEzO47FqwwqiNtxiYx6bT4b-dyrqrVRb4-rY-x8Tf092WEy9STtFH8j2dHUNHxE7Te5TWib3lhUR0Q
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Taylor & Francis Open Access Journals
  dbid: 0YH
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Ni9UwEA-6IngRv-36QQSv1TaZNi_eVnF5CHpyQU8hSSdrkW2X1y66__1O0vbx3qJ48JomJc3MdH6_ZDLD2GslndWrEvIGCsgBG8hXSGRFN1gLsAQB0i3Xz1_q9Ql8-lYt0YTDHFYZOXSYEkWkf3U0buuGJSLuLfFuXZAbJXYnqGlVSyJaN9ktocj7k0oX39fbbZYCQE311OKoPA5b7vH87U17Hiol8r-WxvRPYPR6TOWOkzq-x-7O6JIfTepwn93A7gG7PdWbvHzIkJSCn2_QtT114HMsB-8D78_w1OaSBzuOl9z6tuFDrPc5xZZH4b3jR3xof-e_EH9ycnBNTxqCDW93giZ5qgHyiJ0cf_z6YZ3PdRZyX0kYc8IswhU1ASVB5ME6Qgg6NERMQBG80hV64SvfKKVCRQDE1s4HiQqDVboiIisfs4Ou7_Ap4xACBCd9ENZDCaV2BEBtbWUpPBI3ydibZW3N-ZROw5RzltJFGCYKw8zCyNj7KIFt55gNOzX0m1MzG5cJxPnAOiTdUsSHvQ6AGgm5uJLm7iBjeld-ZkybIWGqXGLkPybwahG2oXWNxym2w_5iMHF5gABcXWTsyST87TSljOerlciY2lOLve_Yf9K1P1J2b6VWJZnJ4X_M-Rm7I2LoTdopes4Oxs0FviDsNLqXyTquAMscDlU
  priority: 102
  providerName: Taylor & Francis
Title The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial
URI https://www.tandfonline.com/doi/abs/10.1080/19490976.2020.1863133
https://www.ncbi.nlm.nih.gov/pubmed/33382352
https://search.proquest.com/docview/2474465860
https://pubmed.ncbi.nlm.nih.gov/PMC7781624
https://doaj.org/article/f1644abe4a47402c9f4e9e124b1ec2b4
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFL00hY2-jH0v-wga7NWJbcmWvbeurIRByx5W6J6EJF91posdEpet_35Xsl2SMhjsJQ-KYyTdE-sc-ehegA-SG10WiYgqEYtIYCWiAkmslBXmqdBEAcIp17PzfHkhvlxmlweQjWdhgmnfmnre_FzNm_pH8FauV3Yx-sQWX89OpCwSutNiAhMC6I5ED49fIWRfQY30ubcDyXw8uVPEC9_mm0gZptRU5JxE2hE85Ny_EMvSveUpZPG_l8P0b0z0vqFyZ4U6fQyPBmrJjvshPIEDbJ7Cg77Y5O0zQEIEW2_Q1C1dwAYjB2sda1d4pSPOnO66W6ZtXbGtL_bZG8t95D6yY7atf0e_EK8ZrW5VS_DAitU7jkkWCoA8h4vTz99OltFQZCGyGRddRIQlNXFOLCkl5aAN0YPSVaRKhCRuVWZoU5vZSkrpMmIfOjfWcZTotCwzUrH8BRw2bYOvgAnnhDPculRbkYikNMQ-da55klokYTKF-Ti3at3n0lDJkKJ0jIvycVFDXKbwyUfg7mKfCjs0tJsrNQBCORJ8QhskYEkSw7Z0Aksk2mIS6rsRUyh346e6sBPi-rIliv-jA-_HYCuaV_8uRTfY3myVnx5B7C2Pp_CyD_5dN0csTUHuwWJvHPvfENJDau8B2a__-5dv4Cj1rpuwSfQWDrvNDb4j2tSZGUzi70v65PH5LGw9zMIf5w8v5xSe
link.rule.ids 230,315,730,783,787,867,888,2109,27514,27936,27937,53804,53806,59475,59476,60218,61007
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMGlKu_wNBJXQxJP4jW3UlEt0PbUSuVk2c64jRBJtZsK-u87zmO1W4E4cHXsaOIZZ77PHs8w9k5JZ_UsA1FBCgKwAjFDIiu6wjIHSxCgv-V6eFTOT-DraXG6dhcmhlVGDh2GRBH9vzou7rgZPYXEfSDirVPyo0TvcmqalZKY1m12p9CgopWn3-erfZYUQA0F1eIoEYdNF3n-9qYNF9Vn8r-Rx_RPaPRmUOWal9rfYdsjvOS7gz08YLewecjuDgUnrx4xJKvgFwt0dUsd-BjMwdvA2594ZoXkwXbdFbe-rvgyFvwcgsuj9j7yXb6sf4tfiD84ebiqJRPBitdrUZO8LwLymJ3sfz7em4ux0ILwhYROEGjJXVoSUsqJPVhHEEGHipgJKMJXukCf-8JXSqlQEAKxpfNBosJglS6IyconbKtpG3zGOIQAwUkfcushg0w7QqC2tDLLPRI5Sdj7aW7NxZBPw2RjmtJJGSYqw4zKSNinqIFV55gOu29oF2dmXF0mEOkD65CMSxEh9joAaiTo4jKS3UHC9Lr-TNfvhoShdImR_xDg7aRsQ_Maz1Nsg-3l0sTpAUJwZZqwp4PyV2JKGQ9YizxhasMsNr5j80lTn_fpvZWaZbROnv-HzG_Yvfnx4YE5-HL07QW7n8c4nH7b6CXb6haX-IqAVOde9yvlGn3xEck
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgEYgL74XwNBLXlCSexDW35VEtr4oDK3GzbGe8RCuSqk0Fy69nnEfVViAOe02TyJ58rr_P_jzD2AsprFHTFOISEogBS4inSGJFlVhkYIgCdKdcP8-L4xP48C0f3YSrwVYZNLTvE0V0_9VhcC9KPzriXpLuVglNo6TuMro0LQQJrcvsShF2_MMpjmS-WWZJAGRfTy08FYfHxnM8_3rTzgzVJfLfS2P6NzK676ncmqRmN5kdu9d7U84m69ZO3O-9zI8X6v8tdmOgsPyox9xtdgnrO-xqX9Ty_C5DQh5fLNFWDd3AB8MIbzxvfuCpiQX3pm3PuXFVyVehqGhvYA8IecWP-Kr6Ff9EPOM0i5YNwRBLXm05M3lXaOQeO5m9-_rmOB6KOcQuF9DGRIwymxTExjJSKMYSDVG-JPUDkjicytFlLnellNLnxHJMYZ0XKNEbqXJSy-KQHdRNjQ8YB-_BW-F8ZhykkCpLLNcURqSZQxJAEZuMH1Av-pwdOh1SoY6x0yF2eohdxF6Hz7y5OaTc7i40y1M9jGDtSViCsUgAliS6nfKACoke2ZTabiFiahskuu1WXHxfHkWL_zTg-YgoTXENezamxma90iE8QCyxSCJ2v0fYpplChE3cPIuY3MHeTj92f6mr710KcSmnKY3Fhxdo8zN27cvbmf70fv7xEbueBatPtzL1mB20yzU-Ia7W2qfdaPwDgcAwcg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+prebiotic+effects+of+omega-3+fatty+acid+supplementation%3A+A+six-week+randomised+intervention+trial&rft.jtitle=Gut+microbes&rft.au=Vijay%2C+Amrita&rft.au=Astbury%2C+Stuart&rft.au=Le+Roy%2C+Caroline&rft.au=Spector%2C+Tim+D&rft.date=2021-01-01&rft.issn=1949-0976&rft.eissn=1949-0984&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1080%2F19490976.2020.1863133&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_19490976_2020_1863133
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1949-0976&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1949-0976&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1949-0976&client=summon